Correlation Between PsyBio Therapeutics and NGM Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and NGM Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and NGM Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PsyBio Therapeutics Corp and NGM Biopharmaceuticals, you can compare the effects of market volatilities on PsyBio Therapeutics and NGM Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of NGM Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and NGM Biopharmaceutica.

Diversification Opportunities for PsyBio Therapeutics and NGM Biopharmaceutica

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between PsyBio and NGM is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and NGM Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NGM Biopharmaceuticals and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with NGM Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NGM Biopharmaceuticals has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and NGM Biopharmaceutica go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and NGM Biopharmaceutica

If you would invest  0.60  in PsyBio Therapeutics Corp on September 14, 2024 and sell it today you would lose (0.59) from holding PsyBio Therapeutics Corp or give up 98.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.37%
ValuesDaily Returns

PsyBio Therapeutics Corp  vs.  NGM Biopharmaceuticals

 Performance 
       Timeline  
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
NGM Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NGM Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, NGM Biopharmaceutica is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

PsyBio Therapeutics and NGM Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PsyBio Therapeutics and NGM Biopharmaceutica

The main advantage of trading using opposite PsyBio Therapeutics and NGM Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, NGM Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NGM Biopharmaceutica will offset losses from the drop in NGM Biopharmaceutica's long position.
The idea behind PsyBio Therapeutics Corp and NGM Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments